BioCryst Pharmaceuticals
BCRX
#4675
Rank
NZ$3.78 B
Marketcap
NZ$14.91
Share price
2.35%
Change (1 day)
-13.43%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): NZ$0.46 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.87 Billion. , an increase over its 2024 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.45 B-407.51%
2024 -NZ$0.15 Billion-61.56%
2023 -NZ$0.39 Billion-7.43%
2022 -NZ$0.42 Billion34.42%
2021 -NZ$0.32 Billion-0.55%
2020 -NZ$0.32 Billion67.88%
2019 -NZ$0.19 Billion7.55%
2018 -NZ$0.18 Billion53.92%
2017 -NZ$0.12 Billion19.29%
2016 -NZ$94.51 Million28.19%
2015 -NZ$73.73 Million-4.8%
2014 -NZ$77.45 Million50.09%
2013 -NZ$51.6 Million-23.29%
2012 -NZ$67.27 Million-26.19%
2011 -NZ$91.13 Million54.78%
2010 -NZ$58.88 Million150.1%
2009 -NZ$23.55 Million-49.43%
2008 -NZ$46.56 Million14.07%
2007 -NZ$40.81 Million-49.31%
2006 -NZ$80.51 Million72.87%
2005 -NZ$46.58 Million22.08%
2004 -NZ$38.15 Million75.3%
2003 -NZ$21.77 Million-25.36%
2002 -NZ$29.16 Million225.05%
2001 -NZ$8.98 Million-56.6%
2000 -NZ$20.67 Million50.63%
1999 -NZ$13.73 Million38.05%
1998 -NZ$9.94 Million-52.46%
1997 -NZ$20.91 Million58.44%
1996 -NZ$13.2 Million-14.44%
1995 -NZ$15.43 Million28.57%
1994 -NZ$12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$16.78 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.15 B 3,644.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-NZ$1.21 Billion-362.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$0.14 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.79 B 73.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.5 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$13.93 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$42.44 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA